Bioconversion of compactin into pravastatin by Streptomyces sp.
Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l−1 from 750 mg compactin l−1 in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l−1 and 1000 mg pravastatin l−1, respectively, with the conversion rate of 10 mg l−1 h−1. Continuous feeding of compactin increased production of pravastatin to 15 mg l−1 h−1.
Unable to display preview. Download preview PDF.
- Haruyuki Y, Tsubokawa S, Endo A (1985) Microbial hydroxylation of compactin (ML-236B) and monacolin K. J. Antibiotics 38: 605–609.Google Scholar
- Holt JG (1994) Bergey's Manual of Determinative Bacteriology, 9th edn. Baltmore: Williams and Wilkins Co.Google Scholar
- Park JW, Lee JK, Kwon TJ, YI DH, Park YI, Kang SM (2001) Purification and characterization of a cytochrome P-450 from pravatstatin-producing Streptomyses sp. Y-110. J. Microbiol. Biotechnol. 11: 1011–1017.Google Scholar
- Shirling EB, Gottlieb D (1966) Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16: 313–340.Google Scholar
- Williams ST, Sharpe ME, Holt JG, Murray RG, Brener DJ, Krieg NR, Mouldar JW, Pfenning N, Sneath PHA, Staley JT (1989) Bergey's Mannual of Systematic Bacteriology, Vol.4. Baltimore: William & Willkins Co.Google Scholar
- Yulin P, Yashphe J, Demain AL (1997) Biotransformation of compactin to pravastatin by Actinomadura sp. 2966. J. Antibiotics 50: 1032–1035.Google Scholar